Gene Therapy Medicinal Products
Gene therapeutics are biological medicinal products. Their active ingredients contain or extis of a nucleic acid (carrier of the genetic information). Gene therapeutics are used to regulate, repair, replace, add to, or remove a nucleic acid sequence. The therapeutic, preventative, and diagnostic effect is in direct connection to the recombinant nucleic acid sequence which the product contains or in direct connection with the product which is formed on the basis of this genetic information.
Hints
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 492 in BAnz AT 06.04.2022 B6.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 03.06.2022
